 "testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus")
Maharashtra government on Saturday said that it will procure the repurposed Ebola drug remdesivir to treat critical Covid-19 patients in the state at a price of Rs 12000 per vial. Since the Indian manufacturers of the drug are yet to have the marketing authorisation for the drug and its innovator Gilead is yet to launch in the market, the state government is open to procuring it from Bangladesh.
Maharashtra has registered more than 80,000 cases of Covid-19 and is the worst affected state in the country.
Maharashtra health minister Rajesh Tope said that the state government has decided to procure
